Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Inventory (2022 - 2025)

Historic Inventory for Gyre Therapeutics (GYRE) over the last 5 years, with Q3 2025 value amounting to $8.9 million.

  • Gyre Therapeutics' Inventory rose 3879.92% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year increase of 3879.92%. This contributed to the annual value of $6.3 million for FY2024, which is 4802.62% up from last year.
  • Latest data reveals that Gyre Therapeutics reported Inventory of $8.9 million as of Q3 2025, which was up 3879.92% from $8.9 million recorded in Q2 2025.
  • Over the past 5 years, Gyre Therapeutics' Inventory peaked at $8.9 million during Q2 2025, and registered a low of $4.3 million during Q4 2023.
  • For the 4-year period, Gyre Therapeutics' Inventory averaged around $6.6 million, with its median value being $6.3 million (2024).
  • In the last 5 years, Gyre Therapeutics' Inventory tumbled by 3007.19% in 2023 and then skyrocketed by 5950.6% in 2025.
  • Over the past 4 years, Gyre Therapeutics' Inventory (Quarter) stood at $6.1 million in 2022, then crashed by 30.07% to $4.3 million in 2023, then skyrocketed by 48.03% to $6.3 million in 2024, then soared by 39.72% to $8.9 million in 2025.
  • Its Inventory stands at $8.9 million for Q3 2025, versus $8.9 million for Q2 2025 and $7.9 million for Q1 2025.